These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 10605870

  • 1. The long-term effect of nicotine on the oral mucosa.
    Wallström M, Sand L, Nilsson F, Hirsch JM.
    Addiction; 1999 Mar; 94(3):417-23. PubMed ID: 10605870
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation.
    Wallström M, Nilsson F, Hirsch JM.
    Addiction; 2000 Aug; 95(8):1161-71. PubMed ID: 11092064
    [Abstract] [Full Text] [Related]

  • 3. Local tolerance of a sublingual nicotine tablet, an open single-centre study.
    Sand L, Lekerud AK, Wallström M, Hirsch JM.
    In Vivo; 2012 Aug; 26(3):463-8. PubMed ID: 22523300
    [Abstract] [Full Text] [Related]

  • 4. A comparison of a nicotine sublingual tablet and placebo for smoking cessation.
    Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CC, Howell RM, Keyes GG, Nilsson F, Hobbs GR.
    Nicotine Tob Res; 2002 Nov; 4(4):441-50. PubMed ID: 12521403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.
    Muramoto ML, Ranger-Moore J, Leischow SJ.
    Nicotine Tob Res; 2003 Apr; 5(2):223-30. PubMed ID: 12745495
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Swift RM, Leggio L, Monti PM.
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.